News & Updates

The investigational benzamide LB-102 (N-methyl amisulpride) is well tolerated and helps reduce symptoms in patients with schizophrenia experiencing an acute episode, according to the results of the NOVA1 phase 2 trial.

In response to increasing need for accurate diagnosis of Alzheimer’s disease (AD) pathology with the availability of anti-amyloid therapies (AATs), a 20-member expert panel in Hong Kong has formulated the first multispecialty consensus recommendations to provide practical locally-tailored guidance for healthcare practitioners on the use of imaging and biomarkers for AD diagnosis and AATs.

Sexual dysfunction (SD) is common among women with diabetes and appears to be driven by age, disease duration, and depression, among others, a study has found.

A geriatric-centred emergency department (ED) observation unit (Geri-EDOU) has improved patient outcomes by using a variety of designs that enable comprehensive geriatric assessment (CGA) for older adults admitted to EDs, reports a Singapore study.

Children with prenatal exposure to buprenorphine do not appear to have an elevated risk of long-term adverse neurodevelopmental outcomes relative to those exposed to methadone, suggests a study.

Acne is common among people with prolonged sedentary behaviour and late bedtime but not among those who regularly engage in physical activity, according to a study.

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

Mental health risks associated with cannabis use disorder (CUD) differ by age and comorbid substance use disorders (SUDs), suggests a study.

Mobile technologies that track blood alcohol concentration (BAC) show potential in reducing alcohol intake among individuals with heavy drinking, reveals a study.